Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis

Neuroscience Letters

Volumn 649, Issue , 2017, Pages 100-106

  Zhang, Ming Liang ^a   Zhang, Xiao Jian ^a   Kang, Jian ^a   Zhang, Hui Jun ^a   Chen, Xiao Long ^a   Liu, Nan ^a   Liu, Shu Qing ^a   Ma, Wen Di ^a   Zhang, Guang Xian ^b   Zhu, Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Arg1; Experimental autoimmune encephalomyelitis; iNOS; Matrine; NT3

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRINE; NEUROTROPHIN 3; ALKALOID; AUTACOID; QUINOLIZINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN HISTOLOGY; CONTROLLED STUDY; DEMYELINATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GLIA CELL; HISTOPATHOLOGY; LUMBAR SPINAL CORD; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROCYTE PROGENITOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPINAL CORD; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GLIA; METABOLISM; PATHOLOGY;

ALKALOIDS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION MEDIATORS; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NEUROGLIA; NEUROTROPHIN 3; QUINOLIZINES; SPINAL CORD;

EID: 85017507448     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2017.04.005     Document Type: Article

References (54)

1. [1] Aharoni, R., Immunomodulation neuroprotection and remyelination—the fundamental therapeutic effects of glatiramer acetate: a critical review. J. Autoimmun. 54 (2014), 81–92.
2. [2] Aharoni, R., Eilam, R., Domev, H., Labunskay, G., Sela, M., Arnon, R., The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 19045–19050.
3. [3] Almad, A.A., Maragakis, N.J., Glia: an emerging target for neurological disease therapy. Stem Cell Res. Ther., 3, 2012.
4. [4] Banerjee, S., Melnyk, S.B., Krager, K.J., Aykin-Burns, N., Letzig, L.G., James, L.P., Hinson, J.A., The neuronal nitric oxide synthase inhibitor NANT blocks acetaminophen toxicity and protein nitration in freshly isolated hepatocytes. Free Radic. Biol. Med. 89 (2015), 750–757.
5. [5] Beutner, C., Lepperhof, V., Dann, A., Linnartz-Gerlach, B., Litwak, S., Napoli, I., Prinz, M., Neumann, H., Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis. Gene Ther. 20 (2013), 797–806.
6. [6] Bogie, J.F., Stinissen, P., Hendriks, J.J., Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol. (Berl.) 128 (2014), 191–213.
7. [7] Bolton, C., Scott, G.S., Smith, T., Flower, R.J., The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS). Eur. J. Pharmacol. 601 (2008), 88–93.
8. [8] Brambilla, R., Morton, P.D., Ashbaugh, J.J., Karmally, S., Lambertsen, K.L., Bethea, J.R., Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia 62 (2014), 452–467.
9. [9] Brown, G.C., Vilalta, A., How microglia kill neurons. Brain Res. 1628 (2015), 288–297.
10. [10] Bussiere, F.I., Chaturvedi, R., Cheng, Y., Gobert, A.P., Asim, M., Blumberg, D.R., Xu, H., Kim, P.Y., Hacker, A., Casero, R.A., Wilson, K.T. Jr., Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J. Biol. Chem. 280 (2005), 2409–2412.
11. [11] Caggiula, M., Batocchi, A.P., Frisullo, G., Angelucci, F., Patanella, A.K., Sancricca, C., Nociti, V., Tonali, P.A., Mirabella, M., Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. Scand. J. Immunol. 62 (2005), 176–182.
12. [12] Cekanaviciute, E., Buckwalter, M.S., Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. Neurotherapeutics 13 (2016), 685–701.
13. [13] Clemente, D., Ortega, M.C., Melero-Jerez, C., de Castro, F., The effect of glia–glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front. Cell. Neurosci., 7, 2013, 268.
14. [14] Constantinescu, C.S., Farooqi, N., O'Brien, K., Gran, B., Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164 (2011), 1079–1106.
15. [15] Correale, J., Villa, A., The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 251 (2004), 1304–1316.
16. [16] Cross, A.H., San, M., Stern, M.K., Keeling, R.M., Salvemini, D., Misko, T.P., A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 107 (2000), 21–28.
17. [17] Fulmer, C.G., VonDran, M.W., Stillman, A.A., Huang, Y., Hempstead, B.L., Dreyfus, C.F., Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. J. Neurosci. 34 (2014), 8186–8196.
18. [18] Girard, C., Bemelmans, A.P., Dufour, N., Mallet, J., Bachelin, C., Nait-Oumesmar, B., Baron-Van Evercooren, A., Lachapelle, F., Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J. Neurosci. 25 (2005), 7924–7933.
19. [19] Gogoi, M., Datey, A., Wilson, K.T., Chakravortty, D., Dual role of arginine metabolism in establishing pathogenesis. Curr. Opin. Microbiol. 29 (2016), 43–48.
20. [20] Igelhorst, B.A., Niederkinkhaus, V., Karus, C., Lange, M.D., Dietzel, I.D., Regulation of neuronal excitability by release of proteins from glial cells. Philos. Trans R. Soc. Lond. B Biol. Sci., 370, 2015.
21. [21] Jean, I., Lavialle, C., Barthelaix-Pouplard, A., Fressinaud, C., Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res. 972 (2003), 110–118.
22. [22] Kan, Q.C., Lv, P., Zhang, X.J., Xu, Y.M., Zhang, G.X., Zhu, L., Matrine protects neuro-axon from CNS inflammation-induced injury. Exp. Mol. Pathol. 98 (2015), 124–130.
23. [23] Karni, A., Urshansky, N., Mausner, K., Fahoum, F., Dysregulated BDNF, NGF and NT3 MRNA production by immune cells of patients with RR-MS. J. Neuroimmunol., 203, 2008, 138.
24. [24] Li, J., Chen, W., Li, Y., Chen, Y., Ding, Z., Yang, D., Zhang, X., Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis. Int. J. Clin. Exp. Pathol. 8 (2015), 11149–11156.
25. [25] Linares, D., Taconis, M., Mana, P., Correcha, M., Fordham, S., Staykova, M., Willenborg, D.O., Neuronal nitric oxide synthase plays a key role in CNS demyelination. J. Neurosci. 26 (2006), 12672–12681.
26. [26] Liu, N., Kan, Q.C., Zhang, X.J., Xv, Y.M., Zhang, S., Zhang, G.X., Zhu, L., Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis. Exp. Mol. Pathol. 97 (2014), 470–476.
27. [27] Liu, X., Yao, D.L., Bondy, C.A., Brenner, M., Hudson, L.D., Zhou, J., Webster, H.D., Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol. Cell. Neurosci. 5 (1994), 418–430.
28. [28] Liu, Y., Xu, Y., Ji, W., Li, X., Sun, B., Gao, Q., Su, C., Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med. 35 (2014), 5111–5119.
29. [29] Mander, P., Borutaite, V., Moncada, S., Brown, G.C., Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J. Neurosci. Res. 79 (2005), 208–215.
30. [30] Mao, Y.M., Zeng, M.D., Lu, L.G., Wan, M.B., Li, C.Z., Chen, C.W., Fu, Q.C., Wang, J.Y., She, W.M., Cai, X., Ye, J., Zhou, X.Q., Wang, H., Wu, S.M., Tang, M.F., Zhu, J.S., Chen, W.X., Zhang, H.Q., Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized double blind, placebo-controlled, multicenter clinical study. World J. Gastroenterol. 10 (2004), 3269–3273.
31. [31] Marchetti, D., Denkins, Y., Reiland, J., Greiter-Wilke, A., Galjour, J., Murry, B., Blust, J., Roy, M., Brain-metastatic melanoma: a neurotrophic perspective. Pathol. Oncol. Res.: POR 9 (2003), 147–158.
32. [32] Mayo, L., Trauger, S.A., Blain, M., Nadeau, M., Patel, B., Alvarez, J.I., Mascanfroni, I.D., Yeste, A., Kivisakk, P., Kallas, K., Ellezam, B., Bakshi, R., Prat, A., Antel, J.P., Weiner, H.L., Quintana, F.J., Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20 (2014), 1147–1156.
33. [33] Mele, T., Carman-Krzan, M., Juric, D.M., Regulatory role of monoamine neurotransmitters in astrocytic NT-3 synthesis. Int. J. Dev. Neurosci. 28 (2010), 13–19.
34. [34] Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A., A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995), 1951–1959.
35. [35] Miron, V.E., Boyd, A., Zhao, J.W., Yuen, T.J., Ruckh, J.M., Shadrach, J.L., van Wijngaarden, P., Wagers, A.J., Williams, A., Franklin, R.J., ffrench-Constant, C., M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16 (2013), 1211–1218.
36. [36] Moore, S., Khalaj, A.J., Yoon, J., Patel, R., Hannsun, G., Yoo, T., Sasidhar, M., Martinez-Torres, L., Hayardeny, L., Tiwari-Woodruff, S.K., Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. Brain Behav. 3 (2013), 664–682.
37. [37] Moyat, M., Velin, D., Immune responses to Helicobacter pylori infection. World J. Gastroenterol. 20 (2014), 5583–5593.
38. [38] Papastefanaki, F., Matsas, R., From demyelination to remyelination: the road toward therapies for spinal cord injury. Glia 63 (2015), 1101–1125.
39. [39] Pena-Altamira, E., Prati, F., Massenzio, F., Virgili, M., Contestabile, A., Bolognesi, M.L., Monti, B., Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation. Expert Opin. Ther. Targets 20 (2016), 627–640.
40. [40] Rawji, K.S., Yong, V.W., The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin. Dev. Immunol., 2013, 2013, 948976.
41. [41] Sahenk, Z., Oblinger, J., Edwards, C., Neurotrophin-3 deficient Schwann cells impair nerve regeneration. Exp. Neurol. 212 (2008), 552–556.
42. [42] Srinivasan, B., Roque, C.H., Hempstead, B.L., Al-Ubaidi, M.R., Roque, R.S., Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J. Biol. Chem. 279 (2004), 41839–41845.
43. [43] Tran, P.V., Chowdhury, V.S., Do, P.H., Bahry, M.A., Yang, H., Furuse, M., L-Ornithine is a potential acute satiety signal in the brain of neonatal chicks. Physiol. Behav. 155 (2016), 141–148.
44. [44] Tzeng, S.F., Huang, H.Y., Lee, T.I., Jwo, J.K., Inhibition of lipopolysaccharide-induced microglial activation by preexposure to neurotrophin-3. J. Neurosci. Res. 81 (2005), 666–676.
45. [45] Valero-Esquitino, V., Lucht, K., Namsolleck, P., Monnet-Tschudi, F., Stubbe, T., Lucht, F., Liu, M., Ebner, F., Brandt, C., Danyel, L.A., Villela, D.C., Paulis, L., Thoene-Reineke, C., Dahlof, B., Hallberg, A., Unger, T., Sumners, C., Steckelings, U.M., Direct angiotensin type 2 receptor (AT(2)R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice. Clin. Sci. 128 (2015), 95–109.
46. [46] Verkhratsky, A., Matteoli, M., Parpura, V., Mothet, J.P., Zorec, R., Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J. 35 (2016), 239–257.
47. [47] Wegner, C., Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Clin. Neurol. Neurosurg. 115:Suppl. 1 (2013), S38–41.
48. [48] Yang, J., Yan, Y., Ma, C.G., Kang, T., Zhang, N., Gran, B., Xu, H., Li, K., Ciric, B., Zangaladze, A., Curtis, M., Rostami, A., Zhang, G.X., Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis. Acta Neuropathol. (Berl.) 124 (2012), 491–503.
49. [49] Yang, J.X., Yan, Y.P., Xia, Y., Kang, T.G., Li, X., Ciric, B., Xu, H., Rostami, A., Zhang, G.X., Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells. Mol. Ther. 22 (2014), 440–450.
50. [50] Zhang, J., Zhang, Z.G., Li, Y., Ding, X., Shang, X., Lu, M., Elias, S.B., Chopp, M., Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis. Neurobiol. Dis. 76 (2015), 57–66.
51. [51] Zhang, J.M., Geula, C., Lu, C.L., Koziel, H., Hatcher, L.M., Roisen, F.J., Neurotrophins regulate proliferation and survival of two microglial cell lines in vitro. Exp. Neurol. 183 (2003), 469–481.
52. [52] Zhao, X., Kan, Q., Zhu, L., Zhang, G.X., Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis. Am. J. Chin. Med. 39 (2011), 933–941.
53. [53] Zhou, J., Cai, W., Jin, M., Xu, J., Wang, Y., Xiao, Y., Hao, L., Wang, B., Zhang, Y., Han, J., Huang, R., 18beta-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination. Sci. Rep., 5, 2015, 13713.
54. [54] Zhu, L., Pan, Q.X., Zhang, X.J., Xu, Y.M., Chu, Y.J., Liu, N., Lv, P., Zhang, G.X., Kan, Q.C., Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. Exp. Mol. Pathol. 100:April 2 (2016), 337–343.